Suppr超能文献

适当延迟原发性肿瘤放疗可能会导致接受 EGFR-TKIs 治疗的非小细胞肺癌患者有更好的长期总生存。

Appropriate delay of primary tumour radiotherapy may lead to better long-term overall survival for non-small cell lung cancer treated with EGFR-TKIs.

机构信息

Department of Thoracic Oncology, Affiliated Hospital of Guizhou Medical University, 1 Beijing Road West, Guiyang, 550004, China.

Department of Thoracic Oncology, Affiliated Cancer Hospital of Guizhou Medical University, 1 Beijing Road West, Guiyang, 550004, China.

出版信息

BMC Cancer. 2024 Aug 26;24(1):1053. doi: 10.1186/s12885-024-12826-1.

Abstract

PURPOSE

The most appropriate time of primary tumor radiotherapy in non-small cell lung cancer(NSCLC) with EGFR-TKIs remains unclear. The aim of this study was to investigate the effect of the time factor of primary tumor radiotherapy on long-term overall survival(OS)and provide a theoretical basis for further clinical research.

PATIENTS AND METHODS

In total, 238 patients with EGFR-TKIs and OS ≥ 12 months were statistically analysed. Patients were grouped: the D group without primary tumor radiotherapy and the R group with it.The R group were divided into three groups according to the interval between the start of EGFR-TKIs and the start of primary tumor radiotherapy: R(<30 days), R(≥ 30 days and disease stable), and R(radiotherapy after disease progression). The Kaplan-Meier method and log-rank test were used for survival analyses. Exploratory landmark analyses were investigated.

RESULTS

The OS rates at 1, 2, 3, 5 years for the R group and D group were 96.8%, 62.9%, 38.3%, 17.1%, and 95.6%, 37.7%, 21.8%, 2.9%, respectively; the corresponding MST was 29 months(95% CI: 24.3-33.7) for the R group and 22 months(95% CI: 20.4-23.6) for the D group (χ = 13.480, p<0.001). Multivariate analysis revealed that primary tumor radiotherapy was independent predictors of prolonged OS.Among the four groups, The R appeared to have the best OS (D, χ = 19.307, p<0.001;R, χ = 11.687, p = 0.01; R, χ = 4.086, p = 0.043). Landmark analyses(22 months) showed the R group had a significant long-term OS.The incidence of radiation pneumonitis ≥ grade 2 was17.3%(n = 19)and radiation esophagitis ≥ grade 2 was observed in 32 patients(29.1%).

CONCLUSIONS

Our results showed that primary tumour radiotherapy may prolong long-term OS with acceptable toxicities. Appropriate delay(R)of primary tumour radiotherapy may be the best choice.Premature radiotherapy(R) and radiotherapy after disease progression (R)may not be reasonable for long-term OS.

摘要

目的

表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKIs)治疗的非小细胞肺癌(NSCLC)患者中,原发肿瘤放疗的最佳时机仍不清楚。本研究旨在探讨原发肿瘤放疗时间因素对长期总生存(OS)的影响,并为进一步的临床研究提供理论依据。

方法

共对 238 例 EGFR-TKIs 治疗后 OS≥12 个月的患者进行统计学分析。患者分为无原发肿瘤放疗的 D 组和有放疗的 R 组。R 组根据 EGFR-TKIs 开始至原发肿瘤放疗开始的间隔时间分为三组:R(<30 天)、R(≥30 天且疾病稳定)和 R(疾病进展后放疗)。采用 Kaplan-Meier 法和对数秩检验进行生存分析。进行探索性 landmark 分析。

结果

R 组和 D 组的 OS 率在 1、2、3、5 年时分别为 96.8%、62.9%、38.3%、17.1%和 95.6%、37.7%、21.8%、2.9%;相应的 MST 为 R 组 29 个月(95%CI:24.3-33.7),D 组 22 个月(95%CI:20.4-23.6)(χ²=13.480,p<0.001)。多因素分析显示,原发肿瘤放疗是延长 OS 的独立预测因素。在这四组中,R 组的 OS 似乎最好(D,χ²=19.307,p<0.001;R,χ²=11.687,p=0.01;R,χ²=4.086,p=0.043)。landmark 分析(22 个月)显示 R 组有显著的长期 OS。≥2 级放射性肺炎的发生率为 17.3%(n=19),32 例(29.1%)发生≥2 级放射性食管炎。

结论

我们的结果表明,原发肿瘤放疗可能延长长期 OS,且毒性可接受。适当延迟(R)原发肿瘤放疗可能是最佳选择。过早放疗(R)和疾病进展后放疗(R)可能不利于长期 OS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ff/11346023/e4da757b0a8f/12885_2024_12826_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验